Maternal immunization: where are we now and how to move forward?

References

• Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370:2211–2218.
   PubMed Web of Science ®Google Scholar
• Sakala IG, Honda-Okubo Y, Fung J, et al. Influenza immunization during pregnancy: benefits for mother and infant. Hum Vaccin Immunother. 2016;12:3065–3071.
   PubMed Web of Science ®Google Scholar
• GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1725–1774.
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Watson AK, Kennedy ED, et al. Vaccines and pregnancy: past, present, and future. Semin Fetal Neonatal Med. 2014;19:161–169.
   PubMed Web of Science ®Google Scholar
• Keller-Stanislawski B, Englund JA, Kang G, et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine. 2014;32:7057–7064.
   PubMed Web of Science ®Google Scholar
• Omer SB. Maternal immunization. N Engl J Med. 2017;376:1256–1267.
   PubMed Web of Science ®Google Scholar
• Baxter D. Approaches to the vaccination of pregnant women: experience from Stockport, UK, with prenatal influenza. Hum Vaccin Immunother. 2013;9:1360–1363.
   PubMed Web of Science ®Google Scholar
• Panda B, Stiller R, Panda A. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Fetal Neonatal Med. 2011;24:402–406.
   PubMed Web of Science ®Google Scholar
• Larson HJ. Maternal immunization: the new “normal” (or it should be). Vaccine. 2015;33:6374–6375.
   PubMed Web of Science ®Google Scholar
• Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63:425–433.
   PubMed Web of Science ®Google Scholar
• Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42:77–103.
   PubMed Web of Science ®Google Scholar
• Gellersen B, Brosens IA, Brosens JJ. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med. 2007;25:445–453.
   PubMed Web of Science ®Google Scholar
• Chaouat G, Petitbarat M, Dubanchet S, et al. Tolerance to the foetal allograft? Am J Reprod Immunol. 2010;63:624–636.
   PubMed Web of Science ®Google Scholar
• Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012;62:263–271.
   PubMed Web of Science ®Google Scholar
• Palmeira P, Quinello C, Silveira-Lessa AL, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012;2012:985646.
   PubMed Web of Science ®Google Scholar
• Faucette AN, Unger BL, Gonik B, et al. Maternal vaccination: moving the science forward. Hum Reprod Update. 2015;21:119–135.
   PubMed Web of Science ®Google Scholar
• Chu HY, Englund JA. Maternal immunization. Clin Infect Dis. 2014;59:560–568.
   PubMed Web of Science ®Google Scholar
• Eberhardt CS, Blanchard-Rohner G, Lemaitre B, et al. Pertussis antibody transfer to preterm neonates after second- versus third-trimester maternal immunization. Clin Infect Dis. 2017;64:1129–1132.
   PubMed Web of Science ®Google Scholar
• Eberhardt CS, Blanchard-Rohner G, Lemaitre B, et al. Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin Infect Dis. 2016;62:829–836.
   PubMed Web of Science ®Google Scholar
• Palmeira P, Carneiro-Sampaio M. Immunology of breast milk. Rev Assoc Med Bras (1992). 2016;62:584–593.
   PubMed Web of Science ®Google Scholar
• De Schutter S, Maertens K, Baerts L, et al. Quantification of vaccine-induced antipertussis toxin secretory IgA antibodies in breast milk: comparison of different vaccination strategies in women. Pediatr Infect Dis J. 2015;34:e149–e152.
   PubMed Web of Science ®Google Scholar
• Schlaudecker EP, Steinhoff MC, Omer SB, et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLoS One. 2013;8:e70867.
   PubMed Web of Science ®Google Scholar
• Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014;5:446.
   PubMed Web of Science ®Google Scholar
• Maertens K, Cabore RN, Huygen K, et al. Pertussis vaccination during pregnancy in Belgium: follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age. Vaccine. 2016;34:3613–3619.
   PubMed Web of Science ®Google Scholar
• Edwards KM. Maternal antibodies and infant immune responses to vaccines. Vaccine. 2015;33:6469–6472.
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Campbell H, Ribeiro S, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis. 2016;63:S236–S243.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Tetanus vaccine. WHO position paper. Wkly Epidemiol Rec. 2006;81:198–208.
   PubMedGoogle Scholar
• Thwaites CL, Beeching NJ, Newton CR. Maternal and neonatal tetanus. Lancet. 2015;385:362–370.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Maternal and neonatal tetanus (MNT) elimination [Internet]. 2016 [cited 2017 Oct 25]. Available from: http://www.who.int/immunization/diseases/MNTE_initiative/en/
   Google Scholar
• World Health Organization. Pertussis vaccines: WHO position paper – September 2015. Wkly Epidemiol Rec. 2015;90:433–458.
   PubMedGoogle Scholar
• Domenech de Celles M, Magpantay FM, King AA, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci. 2016;283. DOI:10.1098/rspb.2015.2309
   PubMed Web of Science ®Google Scholar
• Jakinovich A, Sood SK. Pertussis: still a cause of death, seven decades into vaccination. Curr Opin Pediatr. 2014;26:597–604.
   PubMed Web of Science ®Google Scholar
• Burns DL, Meade BD, Messionnier NE. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge. J Infect Dis. 2014;209: S32–S35.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO SAGE pertussis working group. Background paper. SAGE April 2014 [Internet]. 2014 [cited 2016 Sep 23]. Available from: http://www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf?ua=
   Google Scholar
• Wiley KE, Zuo Y, Macartney KK, et al. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine. 2013;31:618–625.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months – Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1424–1426.
   PubMedGoogle Scholar
• Healy CM, Rench MA, Montesinos DP, et al. Knowledge and attitudes of pregnant women and their providers towards recommendations for immunization during pregnancy. Vaccine. 2015;33:5445–5451.
   PubMed Web of Science ®Google Scholar
• Terranella A, Asay GR, Messonnier ML, et al. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics. 2013;131:e1748–e1756.
   PubMed Web of Science ®Google Scholar
• McMillan M, Clarke M, Parrella A, et al. Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy: a systematic review. Obstet Gynecol. 2017;129:560–573.
   PubMed Web of Science ®Google Scholar
• Gkentzi D, Katsakiori P, Marangos M, et al. Maternal vaccination against pertussis: a systematic review of the recent literature. Arch Dis Child Fetal Neonatal Ed. 2017;102:F456–F463.
   PubMed Web of Science ®Google Scholar
• Vizzotti C, Juarez MV, Bergel E, et al. Impact of a maternal immunization program against pertussis in a developing country. Vaccine. 2016;34:6223–6228.
   PubMed Web of Science ®Google Scholar
• Tomovici A, Barreto L, Zickler P, et al. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine. 2012;30:2647–2653.
   PubMed Web of Science ®Google Scholar
• Halperin BA, Morris A, Mackinnon-Cameron D, et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis. 2011;53:885–892.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women – Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62:131–135.
   PubMed Web of Science ®Google Scholar
• Winter K, Nickell S, Powell M, et al. Effectiveness of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis vaccination in preventing infant pertussis. Clin Infect Dis. 2017;64:3–8.
   PubMed Web of Science ®Google Scholar
• Winter K, Cherry JD, Harriman K. Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants. Clin Infect Dis. 2017;64:9–14.
   PubMed Web of Science ®Google Scholar
• Joint Committee on Vaccination and Immunisation. Minutes of teleconference on Thursday 30 August 2012 10.00 am – 12.00 am and post-teleconference discussion [Internet]. 2012 [cited 2017 Jan 16]. Available from: http://webarchive.nationalarchives.gov.uk/20130402145952/http://media.dh.gov.uk/network/261/files/2012/09/pertussis-teleconference-minute-to-committee-v4.pdf
   Google Scholar
• Public Health England. Pertussis vaccination programme for pregnant women update: vaccine coverage in England, April to June 2017. Health Protect Rep. 2017;11:34.
   Google Scholar
• Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol. 2012;207:S3–S8.
   PubMed Web of Science ®Google Scholar
• Almond D, Currie J. Killing me softly: the fetal origins hypothesis. J Econ Perspect. 2011;25:153–172.
   PubMed Web of Science ®Google Scholar
• Principi N, Senatore L, Esposito S. Protection of young children from influenza through universal vaccination. Hum Vaccin Immunother. 2015;11:2350–2358.
   PubMed Web of Science ®Google Scholar
• Mak TK, Mangtani P, Leese J, et al. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis. 2008;8:44–52.
   PubMed Web of Science ®Google Scholar
• Blanchard-Rohner G, Meier S, Bel M, et al. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn. Pediatr Infect Dis J. 2013;32:1374–1380.
   PubMed Web of Science ®Google Scholar
• Eick AA, Uyeki TM, Klimov A, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med. 2011;165:104–111.
   PubMed Web of Science ®Google Scholar
• Benowitz I, Esposito DB, Gracey KD, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010;51:1355–1361.
   PubMed Web of Science ®Google Scholar
• Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol. 2011;204:S141–S148.
   PubMed Web of Science ®Google Scholar
• Dabrera G, Zhao H, Andrews N, et al. Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14. Euro Surveill. 2014;19:20959.
   PubMedGoogle Scholar
• Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555–1564.
   PubMed Web of Science ®Google Scholar
• Omer SB, Richards JL, Madhi SA, et al. Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: methods and expectations. Vaccine 2015;33:3801–3812.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371:918–931.
   PubMed Web of Science ®Google Scholar
• Steinhoff MC, Katz J, Englund JA, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis. 2017;17:981–989.
   PubMed Web of Science ®Google Scholar
• McMillan M, Porritt K, Kralik D, et al. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine. 2015;33:2108–2117.
   PubMed Web of Science ®Google Scholar
• Haberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013;368:333–340.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Aqil AR, Omer SB, et al. The effects of influenza vaccination during pregnancy on birth outcomes: a systematic review and meta-analysis. Am J Perinatol. 2016;33:1104–1114.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Strom P, Lundholm C, et al. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. BMJ 2015;351:h5585.
   PubMed Web of Science ®Google Scholar
• Donahue JG, Kieke BA, King JP, et al. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011–12. Vaccine. 2017;35:5314–5322.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012;87:461–476.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices – United States, 2013-2014. MMWR Recomm Rep. 2013;62:1–43.
   Web of Science ®Google Scholar
• Ortiz JR, Perut M, Dumolard L, et al. A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Vaccine. 2016;34:5400–5405.
   PubMed Web of Science ®Google Scholar
• Toback SL, Beigi R, Tennis P, et al. Maternal outcomes among pregnant women receiving live attenuated influenza vaccine. Influenza Other Respir Viruses. 2012;6:44–51.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Seasonal influenza vaccination in Europe – Overview of vaccination recommendations and coverage rates in the EU Member States for the 2012–13 influenza season. Sweden: ECDPC; 2015.
   Google Scholar
• Mereckiene J, Cotter S, Nicoll A, et al. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill. 2014;19:20780. DOI:10.2807/1560-7917.ES2014.19.16.20780
   PubMedGoogle Scholar
• Yuet Sheung Yuen C, Yee Tak Fong D, Lai Yin Lee I, et al. Prevalence and predictors of maternal seasonal influenza vaccination in Hong Kong. Vaccine. 2013;31:5281–5288.
   PubMed Web of Science ®Google Scholar
• Ding H, Black CL, Ball S, et al. Influenza vaccination coverage among pregnant women – United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep. 2015;64:1000–1005.
   PubMed Web of Science ®Google Scholar
• Vizzotti C, Neyro S, Katz N, et al. Maternal immunization in Argentina: a storyline from the prospective of a middle income country. Vaccine. 2015;33:6413–6419.
   PubMed Web of Science ®Google Scholar
• Kfouri RA, Richtmann R. Influenza vaccine in pregnant women: immunization coverage and associated factors. Einstein (Sao Paulo). 2013;11:53–57.
   PubMedGoogle Scholar
• Meharry PM, Colson ER, Grizas AP, et al. Reasons why women accept or reject the trivalent inactivated influenza vaccine (TIV) during pregnancy. Matern Child Health J. 2013;17:156–164.
   PubMed Web of Science ®Google Scholar
• Henninger M, Naleway A, Crane B, et al. Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol. 2013;121:741–749.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO position paper on hepatitis A vaccines – June 2012. Wkly Epidemiol Rec. 2012;87:261–276.
   PubMedGoogle Scholar
• Navabakhsh B, Mehrabi N, Estakhri A, et al. Hepatitis B virus infection during pregnancy: transmission and prevention. Middle East J Dig Dis. 2011;3:92–102.
   PubMedGoogle Scholar
• Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988;61:1942–1956.
   PubMed Web of Science ®Google Scholar
• Kim DK, Bridges CB, Harriman KH. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older – United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:88–90.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85:117–128.
   PubMedGoogle Scholar
• World Health Organization. Japanese encephalitis vaccines: WHO position paper – February 2015. Wkly Epidemiol Rec. 2015;90:69–87.
   PubMedGoogle Scholar
• World Health Organization. Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec. 2011;86:241–256.
   PubMedGoogle Scholar
• World Health Organization. Vaccines and vaccination against yellow fever. WHO position paper – June 2013. Wkly Epidemiol Rec. 2013;88:269–283.
   PubMedGoogle Scholar
• World Health Organization. Global Advisory Committee on vaccine safety, 16–17 June 2010. Wkly Epidemiol Rec. 2010;85:285–292.
   Google Scholar
• Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention – United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57:1–28.
   PubMedGoogle Scholar
• Wright JG, Quinn CP, Shadomy S, et al. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2010;59:1–30.
   PubMedGoogle Scholar
• Chaithongwongwatthana S, Yamasmit W, Limpongsanurak S, et al. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev. 2015;1:CD004903. DOI:10.1002/14651858.CD004903.pub3
   PubMedGoogle Scholar
• Acosta PL, Caballero MT, Polack FP. Brief history and characterization of enhanced respiratory syncytial virus disease. Clin Vaccine Immunol. 2015;23:189–195.
   PubMed Web of Science ®Google Scholar
• Modjarrad K, Giersing B, Kaslow DC, et al. WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization meeting held on 23–24 March 2015. Vaccine. 2016;34:190–197.
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Dormitzer PR, Nokes DJ, et al. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 2013;31(Suppl 2):B209–B215.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Vekemans J, Baker CJ, et al. Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res. 2016;5:2355. DOI:10.12688/f1000research.9363.1
   PubMedGoogle Scholar
• Schleiss MR. Cytomegalovirus vaccines under clinical development. J Virus Erad. 2016;2:198–207.
   PubMed Web of Science ®Google Scholar
• Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med. 2009;361:1376–1385.
   PubMed Web of Science ®Google Scholar
• Regan AK. The safety of maternal immunization. Hum Vaccin Immunother. 2016;12:3132–3136.
   PubMed Web of Science ®Google Scholar
• Beeler JA, Lambach P, Fulton TR, et al. A systematic review of ethical issues in vaccine studies involving pregnant women. Hum Vaccin Immunother. 2016;12:1952–1959.
   PubMed Web of Science ®Google Scholar
• Cassidy C, MacDonald NE, Steenbeek A, et al. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants. Hum Vaccin Immunother. 2016;12:2010–2016.
   PubMed Web of Science ®Google Scholar
• Fulton TR, Narayanan D, Bonhoeffer J, et al. A systematic review of adverse events following immunization during pregnancy and the newborn period. Vaccine. 2015;33:6453–6465.
   PubMed Web of Science ®Google Scholar
• Munoz FM, Eckert LO, Katz MA, et al. Key terms for the assessment of the safety of vaccines in pregnancy: results of a global consultative process to initiate harmonization of adverse event definitions. Vaccine. 2015;33:6441–6452.
   PubMed Web of Science ®Google Scholar
• Bonhoeffer J, Kochhar S, Hirschfeld S, et al. Global alignment of immunization safety assessment in pregnancy – the GAIA project. Vaccine. 2016;34:5993–5997.
   PubMed Web of Science ®Google Scholar
• Roberts JN, Gruber MF. Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy. Vaccine. 2015;33:966–972.
   PubMed Web of Science ®Google Scholar
• Medicines and Healthcare products Regulatory Agency. Boostrix®-IPV suspension for injection in pre-filled syringe. Summary of Product Characteristics [Internet]. 2016 [cited 2017 Mar 6]. Available from: https://www.medicines.org.uk/emc/medicine/28679#PREGNANCY
   Google Scholar
• Health Protection Scotland. Vaccination against pertussis (whopping cough) – the replacement of Repevax® with Boostrix®-IPV – an update for registered healthcare practitioners. Questions and Answers [Internet]. 2014 [cited 2017 Mar 6]. Available from: http://www.nes.scot.nhs.uk/media/2699690/faqs-pertussis_final30052014.pdf
   Google Scholar
• Wilson RJ, Paterson P, Jarrett C, et al. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33:6420–6429.
   PubMed Web of Science ®Google Scholar
• Moniz MH, Beigi RH. Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance. Hum Vaccin Immunother. 2014;10:2562–2570.
   PubMed Web of Science ®Google Scholar
• Maertens K, Braeckman T, Top G, et al. Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders, Belgium. Vaccine. 2016;34:5785–5791.
   PubMed Web of Science ®Google Scholar
• Ishola DA Jr, Permalloo N, Cordery RJ, et al. Midwives' influenza vaccine uptake and their views on vaccination of pregnant women. J Public Health (Oxf). 2013;35:570–577.
   PubMed Web of Science ®Google Scholar
• MacDougall DM, Halperin SA. Improving rates of maternal immunization: Challenges and opportunities. Hum Vaccin Immunother. 2016;12:857–865.
   PubMed Web of Science ®Google Scholar
• Gruber MF. The US FDA pregnancy lactation and labeling rule – implications for maternal immunization. Vaccine. 2015;33:6499–6500.
   PubMed Web of Science ®Google Scholar
• World Health Organization, Expert Committee on Biological Standardization. Addendum to: Annex 3 of WHO Technical Report Series, No. 927. Recommendations for the production and control of influenza vaccine (inactivated). Appendix 4. Labelling information of inactivated influenza vaccines for use in pregnant women [Internet]. Geneva, 2016 Oct 17–21. 2016 [cited 2017 May 17]. Available from: http://who.int/biologicals/expert_committee/Label_after_ECBS_HK_28_Oct_2016.clean.pdf
   Google Scholar
• Food and Drug Administration. Medical product communications that are consistent with the FDA-required labeling – questions and answers. Guidance for industry (Draft) [Internet]. 2017 [cited 2017 Apr 30]. Available from: https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm537130.pdf
   Google Scholar
• Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013. Vaccine. 2016;34:968–973.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2016 global summary [Internet]. 2016 [cited 2016 Feb 26]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/schedules
   Google Scholar
• Bodeker B, Walter D, Reiter S, et al. Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany. Vaccine. 2014;32:4131–4139.
   PubMed Web of Science ®Google Scholar
• Gaudelus J, Martinot A, Denis F, et al. Vaccination of pregnant women in France. Med Mal Infect. 2016;46:424–428.
   PubMed Web of Science ®Google Scholar
• National Immunisation Advisory Committee. Immunisation guidelines for Ireland [Internet]. Dublin (Ireland): Health Service Executive; 2016 [cited 2017 Nov 24]. Available from: http://www.hse.ie/eng/health/immunisation/hcpinfo/guidelines/
   Google Scholar
• Department of Health. The Australian immunisation handbook [Internet]. 10th ed. Canberra (Australia): Australian Government, Department of Health; 2015 [cited 2017 Nov 22]. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home
   Google Scholar
• Joint Committee on Vaccination and Immunisation. Minute of the meeting on 3 February 2016, Oxford Martin School, Oxford [Internet]. 2016 [cited 2017 Apr 19]. Available from: https://app.box.com/s/iddfb4ppwkmtjusir2tc/1/2199012147/66698939189/1
   Google Scholar